| Name | Title | Contact Details |
|---|
ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III
Higi began with a simple idea: being healthy should be simple, fun and rewarding. By making the process convenient and automated, we want to provide the most frictionless method for you to play an active role in your personal health and wellness. We are firm believers that understanding and tracking your data is the key first step to achieving your wellness goals. From your basic vitals to physical activity and nutrition, we are building solutions to help you do just that.
Bausch Health Companies Inc. is a global company whose mission is to improve peoples lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology.
MDC Group is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
OPMEDIC Group Inc. is a Outremont, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.